Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Other Working Capital Changes: 2017-2025

Historic Other Working Capital Changes for AC Immune (ACIU) over the last 9 years, with Sep 2025 value amounting to $1.3 million.

  • AC Immune's Other Working Capital Changes rose 161.18% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year decrease of 2.72%. This contributed to the annual value of $2.4 million for FY2024, which is 223.67% up from last year.
  • As of Q3 2025, AC Immune's Other Working Capital Changes stood at $1.3 million, which was down 2.05% from $1.3 million recorded in Q2 2025.
  • Over the past 5 years, AC Immune's Other Working Capital Changes peaked at $2.9 million during Q1 2024, and registered a low of -$1.6 million during Q4 2022.
  • For the 3-year period, AC Immune's Other Working Capital Changes averaged around $348,010, with its median value being $295,839 (2023).
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first plummeted by 495.63% in 2023, then soared by 2,054.32% in 2025.
  • AC Immune's Other Working Capital Changes (Quarterly) stood at -$1.2 million in 2021, then slumped by 34.03% to -$1.6 million in 2022, then surged by 36.57% to -$1.0 million in 2023, then rose by 4.33% to -$978,284 in 2024, then soared by 161.18% to $1.3 million in 2025.
  • Its Other Working Capital Changes stands at $1.3 million for Q3 2025, versus $1.3 million for Q2 2025 and $773,014 for Q1 2025.